PPS
Pharmaceutical ManufacturingUnited States51-200 Employees
PPS was sold in 2023
Recent Technological Innovations PPS's involvement in developing and gaining FDA clearance for advanced medical components like the Persona Solution Femur indicates opportunities to offer tailored manufacturing, regulatory, and quality assurance services to innovative pharmaceutical and medical device companies.
Market Expansion Potential The company's recent FDA approval and product developments suggest a focus on expanding product lines for sensitive patient populations, opening avenues for partnership in personalized medicine, implant customization, and targeted healthcare solutions.
Sustainability and Safety Focus The emphasis on creating alternatives for patients with sensitivities highlights an industry trend towards safer, biocompatible materials, which could create sales prospects for suppliers of biocompatible raw materials, sustainable manufacturing technologies, and certification consulting.
Industry Collaboration Opportunities Given PPS's engagement with leading medical entities and regulatory bodies, there is a strategic opportunity to build collaborations with biotech firms, research institutions, and healthcare providers involved in cutting-edge implant technologies and safety-focused medical devices.
Financial and Strategic Positioning With moderate revenue and funding levels paired with a growth-driven approach, PPS presents an opportunity for service providers to offer scalable solutions in manufacturing, regulatory compliance, and market expansion consulting tailored to mid-sized companies in the pharmaceutical manufacturing sector.
PPS uses 8 technology products and services including LinkedIn Ads, RxJS, amCharts, and more. Explore PPS's tech stack below.
| PPS Email Formats | Percentage |
| First.Last@gobio.com | 93% |
| FLast@gobio.com | 3% |
| First@gobio.com | 2% |
| FirstLast@gobio.com | 1% |
| First.L@gobio.com | 1% |
| First.Last@iconplc.com | 93% |
| FirstLast@iconplc.com | 4% |
| First.L@iconplc.com | 2% |
| Last.First@iconplc.com | 1% |
PPS has raised a total of $165K of funding over 1 rounds. Their latest funding round was raised on Jan 21, 2011 in the amount of $165K.
PPS's revenue is estimated to be in the range of $50M$100M
PPS has raised a total of $165K of funding over 1 rounds. Their latest funding round was raised on Jan 21, 2011 in the amount of $165K.
PPS's revenue is estimated to be in the range of $50M$100M